Sort
326,823 grants matching “clinical trial”
National Lung Screening Trial
$1,620,738Barbara B O'Brien · Westat, Inc. · N01 · FY2009 · CA
THAPCA Trials - Scientific Application
$1,620,709Frank W Moler · University Of Michigan At Ann Arbor · U01 · FY2010 · HL
Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO)
$1,620,699Delbert G Robinson · Feinstein Institute For Medical Research · R01 · FY2019 · MH
Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progression
$1,620,596Leslee J Shaw · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · HL
Modeling aqueous humour outfow based on digital twin of the anterior eye imaged by robotic OCT
$1,620,537Hao F Zhang · Northwestern University At Chicago · R01 · FY2025 · EY
Human papillomavirus (HPV) infection and cervical and anal cancers
$1,620,520Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
$1,620,452Jaime L Matta · Ponce School Of Medicine · U54 · FY2019 · CA
NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTERS
$1,620,342Children'S Hospital &Res Ctr At Oakland · U54 · FY2003 · HL
Addressing the chronic pain epidemic among older adults in underserved community center; The GetActive+ study.
$1,620,259Ana-Maria Vranceanu · Massachusetts General Hospital · R61 · FY2022 · AG
Chemoprevention of arsenic-induced skin cancer
$1,620,244Habibul Ahsan · University Of Chicago · R01 · FY2013 · CA
IND-enabling studies of non-immunogenic gene therapy for ultra-rare DMD patients excluded from dystrophin trials
$1,620,242Hansell H Stedman · University Of Pennsylvania · U01 · FY2025 · NS
Etiology and Treatment of Alcohol Dependence
$1,620,222Lance O. Bauer · University Of Connecticut Sch Of Med/Dnt · P50 · FY2020 · AA
Preclinial Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,620,133Philip Lograsso · Scripps Research Institute, The · U01 · FY2011 · NS
Preclinical Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,620,133Philip Lograsso · Scripps Research Institute, The · U01 · FY2011 · NS
Age of Blood in Children in Pediatric Intensive Care Units
$1,619,967Philip C Spinella · Washington University · U01 · FY2014 · HL
Novel treatment of posttraumatic stress disorder
$1,619,914Yvonne Y. Lai · Anagin · R44 · FY2018 · MH
ADULT AIDS CLINICAL TRIALS UNIT
$1,619,878Duke University · U01 · FY2001 · AI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$1,619,858Rima F Kaddurah-Daouk · Duke University · U01 · FY2021 · AG
Immune Reconstitution
$1,619,845Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
NCTN BIQSFP ANBL1531 (NRT)
$1,619,532Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
Clinical studies of skeletal diseases
$1,619,484Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine
$1,619,441Timothy Fouts · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
Translational Research that Adapts New Science FORMaltreatment prevention (TRANSFORM)
$1,619,405Jennie G Noll · University Of Rochester · P50 · FY2025 · HD
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
$1,619,382Jaime L Matta · Ponce School Of Medicine · U54 · FY2018 · CA
In-Office, Ultrasound-Based Breakage and Removal of Urinary stones
$1,619,137Michael R Bailey · University Of Washington · P01 · FY2019 · DK